Promoter collection, Human CSF2 promoter
Alternative name | U2815-1 |
---|---|
Clone info. | PCR amplified human CSF2 promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 132072406 to 132073823(NC_000005.10); relatively -1383 to +35, where +1 corresponds to 1 nt of NM_000758.4. |
Comment | PCR cloning, forward primer: CTCCACCTGCTCTCTGAAGG; reverse primer: CCTCCAGAGAACTTTAGCCTTTCT. Entire sequence of promoter region has not been confirmed. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human colony stimulating factor 2 (granulocyte-macrophage) genomic DNA |
Depositor|Developer | DNA Bank, | |
Remarks, protocol and/or map (pdf) | RDB07482.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07482 | pGL4-phCSF2 | DNA solution |
Materials & Methods section:
The pGL4-phCSF2 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07482). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07482_A3Hr.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: Sequence file: RDB07482_A3Hra.seq |
---|
>07482_07482_A3Hr_pGL4-4174F_G01_19.ab1 1 GCCGGGGTCA GAACATTTCT CTGGCCTACT GGCCGGTACC TGAGCTCGCT AGCCTCGAGG 61 ATCTCCACCT GCTCTCTGAA GGCTCGCCAA CCTGAGTCCA GCAGAATGTT CTCGCTTGTG 121 TCCAACCCCA CTGGTTTAGG CTGAATCAGC CTCTAGGGCC CAGAGGCACT GCACCTGGAG 181 TAGGGAGCTT CTCCAGTATC AGAGTCACCT TCAGAGGCCT GGAGCCTTTC ATAAAGCAGG 241 TAAGAGGACT CAATAGATGC ATCTGCATGG AAAACATCCT CCCCTCTACC AGGCACCTGT 301 ATGTACAACC AATCACAGCA GCACACATAC ACCCAGAAAT GGGCACGTGT GGGCCCACAC 361 CCCTTTAGCT ATGAAACCCA GGCATGGGGC AGCTTGAGCC AGATACCTTG TGCAAACACA 421 AACTCGTGCT GTCTTCTCTG AACTCCATTG TGAAAATCAA ACACTTGTCA GCCCCTCAAG 481 AGCCTTTAGA TTTCCTACTT CCACACTTCC ACAGAAAGGC CTCTGGAGTT GGGGGATGCT 541 GGGGTTATGT AGGAAATTAA GCCTGGAGGG CCTTGCTGGG GAAGCCATTG TCCCTGTACC 601 TGAGATGGAT GCAGCCACAG CCCTGGAGCC AGCCTGAAGC TCCTGGTGTC TTCTGGGGGC 661 TACATATAGG AG // |
Primer: Sequence file: RDB07482_A3Hrb.seq |
>07482_07482_A3Hr_pGL4-136R_H01_22.ab1 1 GGTCTAATGT TTTTGGCATC TTCCATGGTG GCTTTACCAA CAGTACCGGA TTGCCAAGCT 61 TGGCCGCCGA GGCCAGATCT TGATCCTCCA GAGAACTTTA GCCTTTCTCT CTGTGTACTG 121 GGCTCACTGG CAAAAGAGCT CTTAAATACA CAGAGGAAAT GATTAATGGT GACCACAAAA 181 TGCCAGGGAG GCGGGGGAAC TACCTGAACT GTGGAATCTC CTGGCCCTTA TCAGCCACAC 241 ATGGGAACGG TGAGCCTTTT CCCTAGGTGG TCAGGCTTGG GGGTTTTCAT TAATGAACCT 301 TTCCAAGAAC CGACAGCCCA CCCACCCGCC TTCCTGAGGG CTCTCCAGCC CTCCCTGGGC 361 AGTCTGAATG GGCCTGAGGC TGCCCCCTCC CTCTGAGGGG CACAGTTTGG ACTTCCTGGC 421 CTGGAATGGC TGGGGTGGGG CGTGGGAGAC ACTTAGATAG GGCTCCCCAT CCTGCCTGTA 481 ATCCCAGGGG CCTTTGGGCA GGCTATGCCC GCCCTGGTGC CTCATTCTGA CTCCAGCCTT 541 CCTCTTCTCT GGCCACTGTG AGAGACTTGA GTGTGAGGGG AGCTCTCACA GACCTGCCCC 601 ACTGACAGTT CACATGGGCT CCCACCCAGG ACCTGGAGCA GGGGGCAACC TCAGTCCAGT 661 AAGGGGGGAC CCCTGCC // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content